24
Feb
2025
Rewiring, Not Retiring: Health and Innovation for the Vanguard Generation
Most of my columns tend to focus on the importance and difficulty of applying emerging technologies to biopharma R&D, aiming to accelerate the delivery of impactful medicines to patients. Yet, as long-time readers know, I have an enduring interest in how to sustain health and ward off illness, a discipline that’s sometimes called Preventive Medicine, Preemptive Health, or, the term... Read More
24
Feb
2025
Defend Young Scientists
Biotech thrives on the creative dynamism of young scientists. Always has. Young scientists are under pressure. NIH grants are on hold. If the NIH budget is gutted, and a generation is forced to find other ways to earn a living, then the biotech industry will lose. It might not be clear for the next couple of quarters or next couple... Read More